Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Stem Cell Reports
|
August 5, 2022
Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
Bayardo I Garay, Sophie Givens, Phablo Abreu, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 6, 2023
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors
Sofia Spampinato, Tiziana Rancati, Justyna Magdalena Waskiewicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2021
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study
Andrea Bresolin, Adriana Faiella, Elisabetta Garibaldi, et al.
Stem Cell Reports
|
January 11, 2023
Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
Bayardo I Garay, Sophie Givens, Phablo Abreu, et al.
European Urology Oncology
|
December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
Federico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
Giuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
European Urology
|
June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study
Felix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2025
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence
Federica Ferrario, Ciro Franzese, Suela Vukcaj, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Stem Cell Reports
|
August 5, 2022
Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
Bayardo I Garay, Sophie Givens, Phablo Abreu, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 6, 2023
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors
Sofia Spampinato, Tiziana Rancati, Justyna Magdalena Waskiewicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 27, 2021
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study
Andrea Bresolin, Adriana Faiella, Elisabetta Garibaldi, et al.
Stem Cell Reports
|
January 11, 2023
Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
Bayardo I Garay, Sophie Givens, Phablo Abreu, et al.
European Urology Oncology
|
December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
Federico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
Giuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
European Urology
|
June 24, 2023
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study
Felix Preisser, Raisa S Abrams-Pompe, Piter Jan Stelwagen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2025
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence
Federica Ferrario, Ciro Franzese, Suela Vukcaj, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Page
of 9